CG ONCOLOGY INC. - CO

34,10

27-ноября-24 16:45:00

15 мин. задержка

Акции

+0,20

+0,59%

Сегодняшний диапазон

33,92 - 34,82

ISIN

N/A

Источник

NASDAQ

CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 25th Annual Meeting

20 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire
CG Oncology Reports Third Quarter 2024 Financial Results and Provides Business Updates

12 ноя 2024 08:00:01 Источник Nasdaq GlobeNewswire
CG Oncology Announces Nature Medicine Publication of Phase 1b Study Results Evaluating Cretostimogene Grenadenorepvec in Combination with Nivolumab in Muscle-Invasive Bladder Cancer

11 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire
CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

30 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire
CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business Updates

08 авг 2024 08:23:15 Источник Nasdaq GlobeNewswire
CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec

18 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire
CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC

06 июн 2024 12:14:19 Источник Nasdaq GlobeNewswire
CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual Meeting

24 май 2024 08:00:00 Источник Nasdaq GlobeNewswire
CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates

09 май 2024 08:00:00 Источник Nasdaq GlobeNewswire
Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

03 май 2024 11:23:00 Источник Nasdaq GlobeNewswire
CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024

26 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024

24 апр 2024 10:00:00 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.